Carlos Cueto
Miami Beach, FLNPI 1790368074
Payments from drug & device makers
Across 181 payments — averaging $22.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$436
- Indivior Inc.$360
- Teva Pharmaceuticals USA, Inc.$322
- Otsuka America Pharmaceutical, Inc.$320
- Vanda Pharmaceuticals Inc.$302
- plus $768 from 10 others
What the payments were for
- Food & beverage$4,080100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 72 | $1,571 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 23 | $436 |
| Indivior Inc. | 14 | $360 |
| Teva Pharmaceuticals USA, Inc. | 14 | $322 |
| Otsuka America Pharmaceutical, Inc. | 18 | $320 |
| Vanda Pharmaceuticals Inc. | 10 | $302 |
| Idorsia Pharmaceuticals US Inc | 10 | $207 |
| Lundbeck LLC | 7 | $178 |
| Boston Scientific | 1 | $146 |
| Almatica Pharma LLC | 4 | $78 |
| Neurocrine Biosciences, Inc. | 2 | $53 |
| Acadia Pharmaceuticals Inc | 2 | $33 |
| Johnson & Johnson | 1 | $21 |
| Luye Pharma (USA) Ltd. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.